Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Artiva Biotherapeutics Readies for the Next Phase of Growth with the Appointment of Neha Krishnamohan as CFO and EVP, Corporate Development and Promotion of Jennifer Bush to Chief Operating Officer
Read Article
News
2024
2023
Archive
Search news articles
January 11, 2021
IDEAYA Biosciences Announces Submission of IND Application for MAT2A Development Candidate IDE397 with the U.S. FDA
January 11, 2021
Akouos and Blueprint Genetics Announce the Resonate Program to Improve Access to Genetic Testing for Individuals with Auditory Neuropathy
January 6, 2021
Entrada Therapeutics Appoints Dr. Peter Kim to its Board of Directors
January 6, 2021
Crinetics Pharmaceuticals to Review 2020 Accomplishments and Provide 2021 Plans at 39th Annual J.P. Morgan Healthcare Conference
January 6, 2021
Artiva Biotherapeutics Announces Appointment of Dr. Fred Aslan as President and CEO
January 6, 2021
IDEAYA Biosciences Doses First Patient in a Phase 1 Combination Study of IDE196 and Crizotinib, a cMET Inhibitor
January 6, 2021
Homology Medicines Announces Plans for Three Clinical Programs in 2021 Spanning Phenylketonuria (PKU) and Hunter Syndrome (MPS II)
December 16, 2020
Scientist.com to Acquire HealthEconomics.Com, the World’s Leading Connected Community for Health Economics and Outcomes Research
December 15, 2020
NodThera Appoints Chief Medical Officer and Chief Financial Officer
December 15, 2020
Cidara Therapeutics Appoints Biotechnology Industry Veteran Christopher Kurtz as Executive Vice President of Technical Operations
« Previous Page
1
…
30
31
32
33
34
…
103